[1]
|
Tyldesley S,Boyd C,Schiclze K,et al.Estimating the need for radiotherapy for lung cancer:an evidence-based epidemiologic approach.Int J Radiat Oncol Biol Phys,2001,49 (4):973-985. |
[2]
|
Rivera MP.Multimodality therapy in the treatment of lung cancer.Semin Respir Crit Care Med,2004,25(Suppl 1):3-10. |
[3]
|
Santos R,Colonias A,Parda D,et al.Comparison between sublobar resection and 125-Iodine brachytherapy after sublobar resection in high-risk patients with stage I non-small-cell lung cancer.Surgery,2003,134(4):691-697. |
[4]
|
Timmerman R,Papiez L,McGarry R,et al.Extracranial stereotactic radioablation:Results of a phase I study in medically inoperable stage I non-small cell iung cancer.Chest,2003,124(5):1946-1955. |
[5]
|
Williamson JF,Coursey BM,Dewerd LA,et al.On the use of apparent activity (Aapp) for treatment planning of 125I and 100pd interstitial brachytherapy sources:recommendations of the American Association of Physicists in Medicine radiation therapy subcommittee on low-energy brachytherapy source dosimetry.Med Phys,1999,26(12):2529-2530. |
[6]
|
Voynov G,Heron DE,Lin CJ,et al.Intraoperative 125I vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer.Brachytherapy,2005,4(4):278-285. |
[7]
|
Uematsu M,Shioda A,Suda A,et al.Computed tomography-guided frameless stereotactic radiotherapy for stage 1 non small cell lung cancer:A 5-year experience.Int J Radiat Oncol Biol Phys,2001,51,(3):666-670. |
[8]
|
Martinez-Monge R,Garrán C,Vivas I,et al.Percutaneous CT-guided 103Pd implantation for the medically inoperable patient with T1N0M0 non-small cell lung cancer:A case report.Brachytherapy,2004,3(3):179-181. |
[9]
|
Fernando HC,Santos RS,Benfield JR.Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer.J Thorac Cardiovasc Surg,2005,129(2):261-267. |
[10]
|
Birdas TJ,Koehler RP,Colonias A.Sublobar resection with brachytherapy versus lobectomy for stage lb non small cell lung cancer.Ann Thorac Surg,2006,81(2):434-439. |
[11]
|
Chen A,Galloway M,Landreneau R,et al.intraoperative 125Ibrachytherapy for high-risk stage I non-small cell lung carcinoma,Int J Radiat Oncol Biol Phys,1999,44(5):1057-1063. |
[12]
|
Nori D,Li X,Pugkhem T.Intraoperative brachytherapy using Gelfoam radioactive plaque implants for resected stage III non-small cell lung cancer with positive margin:A pilot study.J Surg Oncol,1995,60(4):257-261. |
[13]
|
Birdas TJ,Koehler RP,Colonia SA,et al.Sublobar resection with brachytherapy versus lobectomy for stage ib nonsmall cell lung cancer.Ann Thorac Surg,2006,81(2):434-438. |
[14]
|
Lee W,Daly BD,Dipetrillo TA,et al.Limited resection for non-small cell lung cancer observed local control with implantation of I-125 brachytherapy seeds.Ann Thorac Surg,2003,75(1):237-242. |
[15]
|
Nag S,Kelly JF,Non D.Brachytherapy for carcinoma of the lung.Oncology (Huntington),2001,15(3):371-381. |
[16]
|
d'Amato TA,Galloway M,Szydlowaki G,et al.Intraoperative brachytherapy following thoracoscopic wedge resection of stage I lung cancer.Chest,1998,114(4):1112-1115. |
[17]
|
Pisch J,Belsley SJ,Ashton R,et al.Placement of 125I implants with the da vinci robotic system after video-assisted thoracoscopic wedge resection:a feasibility study.Int J Radiat Oncol Biol Phys,2004,60(3):928-932. |